With Help From A Fosamax Femur Lawyer, Non-u.s. Citizens Can Sue Merck
Merck, like many companies, views overseas markets as potentially huge sources of new revenue, and is attempting to tap into them as part of an overall growth strategy. According to Merck, it ranks fifth in market share in emerging markets, and this year plans to introduce 10 new drugs to overseas markets. The company hopes to have emerging market drug sales account for one quarter of its total sales by 2013. Currently, emerging market sales comprise 18 percent of Mercks total revenue.
But an expanding customer base does not come without risk. In general, a company that does business in foreign countries is subject to those countries laws. Although local laws differ, many countries, especially those in Europe and Asia, are adoptingproduct liability standards that are comparable to those in the U.S. This means that more and more often, U.S.-based manufacturers face the prospect of being sued by the citizens of other countries over harm their products cause.
A non-U.S. citizen who has suffered a low energy femur fracture after taking Fosamax has two options for legal recourse. One entails hiring a local lawyer and filing a lawsuit against Merck from within their home country. The other option is to secure legal counsel in the United States, a process made relatively simple by the internet.
The Rottenstein Law Group is interested in helping anyone who has been injured by Fosamax. Regardless of where you live, the fact remains that Merck sold a product to millions of people without properly researching it or warning of its potential side effects. The company now is admitting no wrongdoing, leaving victims no other option but to file a lawsuit and hold Merck responsible for its negligence. At RLG, making powerful corporations redress the harm theyve caused innocent consumers is our business. Our Fosamax femur lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm at the hands of companies like Merck.